4-(4-Fluoro-benzoyloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C17H22FNO4, MW: 323.37
![]() |
- $429 - $543.9
- Product name: 4-(4-Fluoro-benzoyloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C17H22FNO4, MW: 323.37
- CAS: 1065484-34-5
- MF: C17H22FNO4
- MW: 323.36
- EINECS:
- MDL Number:MFCD10698989
- Synonyms:4-(4-Fluoro-benzoyloxy)-piperidine-1-carboxylic acid tert-butyl ester, 98+% C17H22FNO4, MW: 323.37;4-[(4-Fluorobenzoyl)oxy]-1-piperidinecarboxylic acid tert-butyl ester;1-Piperidinecarboxylic acid, 4-[(4-fluorobenzoyl)oxy]-, 1,1-dimethylethyl ester
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Chemenu
- Crysdot
Package
- 500MG
- 1g
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberHCH0294989
- Product descriptionTERT-BUTYL-4-((4-FLUOROBENZOYL)OXY)PIPERIDINE-1-CARBOXYLATE 95.00%
- Packaging500MG
- Price$543.9
- Updated2021-12-16
- Buy
- ManufacturerChemenu
- Product numberCM155693
- Product descriptiontert-butyl4-((4-fluorobenzoyl)oxy)piperidine-1-carboxylate 95%
- Packaging1g
- Price$429
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11357399
- Product descriptiontert-Butyl4-((4-fluorobenzoyl)oxy)piperidine-1-carboxylate 95+%
- Packaging1g
- Price$455
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | HCH0294989 | TERT-BUTYL-4-((4-FLUOROBENZOYL)OXY)PIPERIDINE-1-CARBOXYLATE 95.00% | 500MG | $543.9 | 2021-12-16 | Buy |
Chemenu | CM155693 | tert-butyl4-((4-fluorobenzoyl)oxy)piperidine-1-carboxylate 95% | 1g | $429 | 2021-12-16 | Buy |
Crysdot | CD11357399 | tert-Butyl4-((4-fluorobenzoyl)oxy)piperidine-1-carboxylate 95+% | 1g | $455 | 2021-12-16 | Buy |
Properties
Boiling point :406.6±35.0 °C(Predicted)
Density :1.19
pka :-2.89±0.40(Predicted)
Density :1.19
pka :-2.89±0.40(Predicted)
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|